Inflammation and Cancer
Mechanisms, Diagnosis, and Therapeutic Strategies
- 1st Edition - April 24, 2026
- Latest edition
- Editors: Anoop Kumar, Neeraj Mishra, Arun Kumar Singh, Ashutosh Pareek, Pranav Kumar Prabhakar
- Language: English
Inflammation and Cancer: Mechanisms, Diagnosis, and Therapeutic Strategies delves into the intricate relationship between inflammation and cancer, a crucial area of contem… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
This title offers substantial benefits to researchers, clinicians, and healthcare professionals by providing a thorough understanding of the cellular and molecular pathways linking inflammation and cancer, aiding in the development of effective anti-cancer immunotherapies. By highlighting the latest research and potential therapeutic strategies, this book serves as an essential resource for anyone dedicated to combating cancer through innovative and informed immunotherapeutic approaches.
Key features
Key features
- Explores the intricate relationship between inflammation and cancer, tumor initiation, and progression
- Provides a comprehensive analyses of inflammatory pathways in various cancers
- Offers insights into molecular mechanisms and the inflammatory signaling pathways crucial for developing effective anti-cancer therapies
- Highlights innovative immunotherapeutic strategies and preventive measures to more effectively target cancer
- Conveys the latest research advancements and future directions in cancer-related inflammation studies
Readership
Readership
Table of contents
Table of contents
2. Inflammatory Pathways in Breast Cancer Development
3. Inflammatory Pathways in Oral Cancer Development
4. Inflammatory Pathways in Lung Cancer Development
5. Inflammatory Pathways in Prostate Cancer Development
6. Inflammatory Pathways in Skin Cancer Development
7. Inflammatory Pathways in Development of GIT Related Cancers
8. From Inflammation to Invasion: Understanding Tumorigenesis and Metastasis
9. Preventive Strategies and Public Health Implications for Management of Cancer and Inflammation
10. Inflammatory Biomarkers for Cancer Diagnosis
11. Unraveling Inflammation's Role in Tumorigenesis: Toward Rational Anti-Cancer Therapeutic Design
12. Unraveling Platelets' Dual Role: Bridging Inflammation and Cancer Toward Innovative Therapeutic Strategies
13. Targeting Tumor-Associated Macrophages: Novel Therapeutic Strategies and Future Directions in Cancer Treatment
14. A New Approach to Cancer Treatment: Reducing Inflammation
15. Recent Advances, Current Challenges and Future Perspectives
Product details
Product details
- Edition: 1
- Latest edition
- Published: April 24, 2026
- Language: English
About the editors
About the editors
AK
Anoop Kumar
Dr. Anoop Kumar is an Assistant Professor in the Department of Pharmacology at Delhi Pharmaceutical Sciences & Research University (DPSRU), India. With a distinguished career, he has previously served as an Assistant Professor and Head at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and as Head and Associate Professor at ISF College of Pharmacy, Moga, Punjab. Dr. Kumar has also held research positions at Sun Pharmaceutical Industries Limited and Translational Health Science Institute (THSTI). He earned his Ph.D. from Birla Institute of Technology, Mesra, Ranchi, as a DST INSPIRE Fellow. He is an Associate Editor for Health Sciences Review and Acta Neurologica Scandinavica. His research focuses on drug repurposing, clinical trial meta-analysis, pharmacoeconomics, and pharmacovigilance.
NM
Neeraj Mishra
AS
Arun Kumar Singh
Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.
Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer.
In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.
AP
Ashutosh Pareek
Dr. Ashutosh Pareek, Professor at Banasthali Vidyapith with over 15 years of experience in pharmaceutical sciences, holds gold medals for his Master's and Bachelor's degrees in Pharmacy. Dr. Pareek specializes in neuropharmacology and innovative drug delivery systems, focusing on neurodegenerative disorders, cancer, and autoimmune diseases. His research includes developing advanced drug delivery systems for immunomodulators like naringenin. Dr. Pareek leads a research team working on these critical health issues and has published over 45 research papers and authored five technical books. He holds an international formulation patent and has received numerous awards, including the Zee National Achievers Award 2023. His work is funded by national and international agencies such as ICMR, DST-SERB, DBT, the American Association of Pharmaceutical Scientists, and the International Brain Research Organization. He serves as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology and reviews for leading journals by Elsevier, Springer, and Bentham.
PP
Pranav Kumar Prabhakar
Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.